DRUG · Mapped RxNorm record
Ambrisentan
Normalized identity: ambrisentanView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529
NCT01342952
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedLong-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Hypertension, Pulmonaryunresolved
Interventions
AmbrisentanDRUG · verified · RxNorm: ambrisentan
Sponsors & collaborators
GlaxoSmithKlinelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01342952 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.